Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Zimmer Biomet Holdings    ZBH

ZIMMER BIOMET HOLDINGS

(ZBH)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
03/26/2020 03/27/2020 03/30/2020 03/31/2020 04/01/2020 Date
100.85(c) 94.94(c) 98.28(c) 101.08(c) 89.63(c) Last
2 254 072 1 849 970 2 024 774 1 923 742 1 713 846 Volume
+4.15% -5.86% +3.52% +2.85% -11.33% Change
More quotes
Financials (USD)
Sales 2020 6 431 M
EBIT 2020 1 180 M
Net income 2020 567 M
Debt 2020 6 313 M
Yield 2020 1,15%
Sales 2021 8 272 M
EBIT 2021 2 278 M
Net income 2021 1 313 M
Debt 2021 5 124 M
Yield 2021 1,20%
P/E ratio 2020 24,7x
P/E ratio 2021 14,1x
EV / Sales2020 3,86x
EV / Sales2021 2,86x
Capitalization 18 525 M
More Financials
Company
Zimmer Biomet Holdings specializes in designing, manufacturing, and selling orthopedic and dental reconstruction implants, spinal implants, and traumatology products. Net sales break down by family of products as follows: - reconstruction implants (59.4%): knees replacement (59.2% of net sales),... 
More about the company
Surperformance© ratings of Zimmer Biomet Holdings
Trading Rating : Investor Rating :
More Ratings
Latest news on ZIMMER BIOMET HOLDINGS
03/26ZIMMER BIOMET HOLDINGS : Ex-dividend day for
FA
03/20ZIMMER BIOMET HOLDINGS, INC. : Entry into a Material Definitive Agreement, Creat..
AQ
03/19ZIMMER BIOMET HOLDINGS, INC. : Entry into a Material Definitive Agreement, Finan..
AQ
03/13ZIMMER BIOMET : Free Writing Prospectus - Filing under Securities Act Rules 163/..
PU
03/10ZIMMER BIOMET : Announces Quarterly Dividend for First Quarter of 2020
PR
03/02ZIMMER BIOMET : to Present at Raymond James and Associates' 41st Annual Institut..
AQ
02/28ZIMMER BIOMET : to Present at Raymond James & Associates' 41st Annual Institutio..
PR
02/25ZIMMER BIOMET HOLDINGS : Report
CO
02/21ZIMMER BIOMET : Management's Discussion and Analysis of Financial Condition and ..
AQ
02/05BACTIGUARD PUBL : Year-end report 2019 Bactiguard Holding AB
AQ
02/04ZIMMER BIOMET : Description Reconciliation of Debt to Net Debt and Net Debt Leve..
PU
02/04ZIMMER BIOMET : Description Non-GAAP Financial Guidance
PU
02/04ZIMMER BIOMET : Description Reconciliation of Operating Profit & Margin to Adjus..
PU
02/04ZIMMER BIOMET : Description Reconciliation of Effective Tax Rate to Adjusted Eff..
PU
02/04ZIMMER BIOMET : Description Reconciliation of Cash Flow from Operating Activitie..
PU
More news
News in other languages on ZIMMER BIOMET HOLDINGS
03/26ZIMMER BIOMET HOLDINGS : Ex-dividend day for
03/03IMPLANET : nomination d'un responsable pour l'Allemagne
01/30ZIMMER BIOMET HOLDINGS : Veröffentlichung des Jahresergebnisses
01/30ZIMMER BIOMET HOLDINGS : publication des résultats annuels
2019ZIMMER BIOMET HOLDINGS : Ex-dividend day for
More news
Chart ZIMMER BIOMET HOLDINGS
Duration : Period :
Zimmer Biomet Holdings Technical Analysis Chart | ZBH | US98956P1021 | MarketScreener
Technical analysis trends ZIMMER BIOMET HOLDINGS
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 31
Average target price 156,60  $
Last Close Price 89,63  $
Spread / Highest target 112%
Spread / Average Target 74,7%
Spread / Lowest Target 3,76%
EPS Revisions
Managers
NameTitle
Bryan C. Hanson President, Chief Executive Officer & Director
Larry C. Glasscock Non-Executive Chairman
Kenneth R. Tripp Senior VP-Global Operations & Logistics
Suketu P. Upadhyay Executive VP, Chief Financial & Accounting Officer
David J. Kunz VP-Global Quality, Clinical & Regulatory Affairs
Sector and Competitors
1st jan.Capitalization (M$)
ZIMMER BIOMET HOLDINGS-40.12%20 891
MEDTRONIC PLC-20.51%120 856
BAXTER INTERNATIONAL INC.-2.91%41 180
HOYA CORPORATION-5.74%32 156
TERUMO CORPORATION-3.23%25 993
DEXCOM, INC.23.10%24 664